SG Americas Securities LLC Makes New Investment in Omada Health, Inc. $OMDA

SG Americas Securities LLC bought a new stake in Omada Health, Inc. (NASDAQ:OMDA) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 827,447 shares of the company’s stock, valued at approximately $10,401,000. SG Americas Securities LLC owned 1.40% of Omada Health at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Geode Capital Management LLC acquired a new stake in Omada Health in the 2nd quarter valued at $637,000. Walleye Capital LLC acquired a new position in shares of Omada Health during the second quarter worth about $458,000. Ilex Capital Partners UK LLP purchased a new stake in shares of Omada Health in the second quarter worth about $201,000. Soros Fund Management LLC acquired a new stake in shares of Omada Health in the second quarter valued at about $640,000. Finally, Raymond James Financial Inc. acquired a new stake in shares of Omada Health in the second quarter valued at about $32,000.

Analyst Upgrades and Downgrades

Several research firms recently commented on OMDA. Weiss Ratings reissued a “sell (e+)” rating on shares of Omada Health in a research report on Thursday, June 4th. Canaccord Genuity Group set a $24.00 price objective on shares of Omada Health in a research note on Friday, May 8th. BMO Capital Markets reduced their target price on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, March 6th. Wells Fargo & Company upped their target price on shares of Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. Finally, Barclays raised their price target on shares of Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $22.91.

Insider Activity at Omada Health

In other news, CAO Craig Gracey sold 2,083 shares of the business’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $19.01, for a total value of $39,597.83. Following the completion of the sale, the chief accounting officer owned 5,025 shares of the company’s stock, valued at approximately $95,525.25. The trade was a 29.31% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, President Wei-Li Shao sold 4,589 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $17.24, for a total transaction of $79,114.36. Following the completion of the sale, the president owned 316,238 shares in the company, valued at approximately $5,451,943.12. This trade represents a 1.43% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 78,346 shares of company stock worth $1,411,799 over the last quarter. Company insiders own 6.38% of the company’s stock.

Omada Health Trading Up 10.5%

Omada Health stock opened at $20.89 on Friday. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92. The stock has a market cap of $1.24 billion and a P/E ratio of -77.37. The stock has a 50 day moving average of $16.51 and a 200-day moving average of $14.85.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The business had revenue of $78.05 million during the quarter. As a group, equities analysts predict that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.